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The tyrosine-specific kinases pp60”-= and pp60c”‘cN (pp6Oy are slightly enriched and activated in growth cones isolated from neuronally 
differentiating SH-SYSY neuroblastoma cells. In the growth cones the two src isoforms are associated with a 38 kDa protein. In this report, we 
have compared the sub~llular distribution of pp59’y” and p~62~-~~ with that of ~~60”” in differentiating SH-SYSY cells. Like pp60”“, the other 
two tyrosine kinases were slightly enriched and activated in the growth cones as compared to the levels in the cell bodies. The kinase activites were 
3- to 4-times higher in growth cones than in cell bodies. However, only ~~60”” formed a complex with the 38 kDa protein while immunoprecipitation 
of pp59’m brought down an additional protein of 90 kDa. Tbis may suggest hat these related tyrosine kinases have different substrates and in 
part mediate different cellular responses in the growth cones of differentiating SH-SYSY cells. 
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1. INTRODUCTION 
The src-family of non-receptor tyrosine kinases con- 
sist, at least, of nine structurally related members; c-src, 
c-yes, c-fgr, fyn, lyn, lck, hck, blk and atk. They all have 
a molecular weight of approximately 60 kDa, are 
myristylated in the amino-terminus, and are associated 
with the inside surface of the plasma membrane [l-3]. 
The precise functions of these kinases are not known, 
but ~~56’“~ and ~~59~~ are ~plicated in the intracellu- 
lar signalling of antigen-activated T lymphocytes [4-61, 
while pp60”““, ~~59~~ and pp62=F in fibroblasts are 
involved in the signal transduction pathway via the 
platelet-derived growth factor receptor [7]. The most 
studied member, pp60”-““, is expressed in all tissues 
tested, with the highest levels in the developing nervous 
system and in platelets [8-141. In euronal cells, alterna- 
tive mRNA splicing generates three mRNA species and 
at least two protein products of the src-gene, pp60”“” 
and pp60GSXN [15-l 71. 
Human SH-SY 5Y neuroblastoma cells differentiate 
neuronally in the presence of serum and 12-Gtetrade- 
canoylphorbol- 13-acetate (TPA) [ 18-211. pp60”“” and 
pp60c+mN (collectively called pp6D”“) are activated early 
during differentiation, coinciding in time with the for- 
mation of neurites with growth cones [19], and pp60”‘” 
*Corresponding author. Fax: (46) 18 55 89 31. 
Abbreviations: TPA, 12-0-tetradecanoylphorbol-13-acetate; ppW”, 
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is slightly enriched and activated in these structures [22]. 
Furthermore, during differentiation pp60”” associates 
with a 38 kDa protein (pp38), and this complex is al- 
most exclusively found in the growth cones [22]. A sim- 
ilar complex is also present in chromati granule mem- 
branes [23], and recently ~~62”~~~ was shown to associ- 
ate with a 38 kDa phosphoprotein in adult rat cerebel- 
lum [24]. 
The expression profile and subcellular localization of 
the c-src isoforms suggest roles in the nerve cell func- 
tion. However, mice homozygous for a null mutation in 
the cwrc gene show no abnormalities in the nervous 
system [25], suggesting redundancy mechanisms pre- 
sumably involving other members of the src-kinase fam- 
ily. We have therefore analysed the subcellular distribu- 
tion of ~~59’~ and pp620yes in TPA-treated SH-SYSY 
cells, and the potential association of these tyrosine ki- 
nases to pp38 previously shown to associate to pp60”‘“. 
We find that all kinases are slightly enriched and acti- 
vated in the growth cones. However, neither ~~59~~ nor 
~~62”‘~ appear to associate with a 38 kDa phosphopro- 
tein. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
The SH-SYSY cells, an adrenergic lone of the human neuroblas- 
toma cell line SK-N-SH [26], was kindly provided by Dr. June Biedler, 
Sloan Kettering Institute, New York. The ~~91s were routinely grown 
in Eagle’s minimum essential medium supplemented with serum and 
antibiotics, and neuronal differentiation was induced by treatment 
with 16 nM TPA (Sigma) as described previously [27]. All cells were 
grown for 4 days in the absence or presence of TPA, before analysis. 
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2.2. S~beell~lar fractionation 
The growth cone and the cell body fractions were prepared as 
described in 1221. Briefly, ceils were suspended in ice-cold EDTA 
buffer (0.54 mM EDTA, 137 mM NaCl, 10 mM Na,HPO.,, 2.7 mM 
KCl, 0.15 mM KH&Q, pH 7.4) and homogenized in a Teflon glass 
homogenizer. The homogenate was layered onto a cushion of 20% 
sucrose and centrifugated at 500 x g,, for 4 min. The growth cone 
fraction was collected from the material retained at the lead/20% 
sucrose interface and the pellet in the bottom of the tube represented 
the cell body fraction, Each fraction was centrifugated at 20,000 x g,, 
for 20 min before further analysis. The pelleted growth cones and cell 
bodies were solubilized in RIPA buffer (10 mM Tris-HCL, pH 7.2, 
0.16 M NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% so- 
dium dodecyl sulfate (SDS), 1 mM EGTA, 1 mM EDTA and 100 ,uM 
pre-boiled sodium o~hovanadate), and subjected to i~unopr~ipi- 
tation. 
2.3. Immunoprecipitation, kinase assay and immunoblotting 
~~60’” was immunoprecipitated as in [19] using an excess of the 
monoclonal antibody 327 (MAb 327) [28] followed by incubation with 
rabbit anti-mouse Ig antiserum and formaldehyde-fixed Staphylococ- 
cus aureus. pp5PfYn and pp62C*yye’ w re immunoprecipitated with the 
polyclonal antisera, anti-fyn2 and anti-yes3 [7,29], respectively. The 
solubilized samples were incubated with an excess of the antibody for 
90 min on ice, and then incubated with formaldehyde-fixed S. aureus, 
as described in [19]. 
For kinase assay the immunop~ipitates was resuspended in 20 ~1 
kinase buffer (0.05 M PIPES, pH 6.8, 10 mM MnC12, 0.5 ,uM ATP, 
5 mM MgClJ supplemented with 2.5 &i [Y-~*P]ATP and incubated 
on ice for 20 min. The reactions were terminated with sample buffer 
for SDS-PAGE [30], The proteins were separated on 10% poly- 
acrylamide gels and the 3ZP-labelled protein bands were identified by 
autoradiography and quantified by a phospho-imager (Molecular Dy- 
namics). 
For immunoblotting the immune-complexes were separated by 
SDS-PAGE, and electrophoretically transferred to nitrocellulose fil- 
ters [31]. Then the filters were blocked in 1% non-fat dry-milk, dis- 
solved in phosphate buffered saline (PBS) supplemented with 0.5% 
Tween-20, for 1 h at room temperature. The filters were incubated 
with either MAb 327, antilfynl or anti-yes3 antibodies, diluted I:100 
in PBS, overnight at 4°C. The MAb 327 filters were incubated with 
rabbit anti-mouse Ig antiserum (1:200) for 2 h at room temperature. 
All filters were finally incubate with ‘2sI-labelled protein A (0.25 
.&i/ml; Ra~~he~~l Centre, Amersham, England), in PBS for 2 h 
at room temperature. The proteins were visualized by autoradiogra- 
phy. Three washings with PBS were performed between each antibody 
incubation. The 12sI-labeled protein bands were quantified by a 
phospho-imager. 
2.4. Specific kinase activity of ppS9’y” and pp62’-yes 
To examine the specific kinase activity of ~~59”” and pp62”y”“, the 
immunoprecipitated proteins were divided into two parts and analysed 
for kinase activity and protein content as described above. 
The radioactive protein bands, in the kinase and in the immunoblot 
analyses, were quantified using a phospho-imager analyser and the 
relative specific kinase activities were calculated as the ratio of relative 
kinase activity to relative protein content (see also [22]). The specific 
kinase activities of the cell body fraction were set to 1.0. 
3. RESULTS 
3.1. pp59fy” and pp62cTyes kinase activity and protein lev- 
els in growth cone and cell body fractions from dif- 
ferentiating SH-SYS Y cells 
We have previously reported the enrichment and 
slight activation of ~~60”” in a growth cone preparation 
from differentiating SH-SYSY cells [22]. To examine if 
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other src-related tyrosine kinases were also enriched 
and/or activated in this cell compartment, a growth 
cone and a cell body preparation were analysed for 
~~59~~ and pp62”Yes. The pelleted, fractionated material 
was solubilized, whereafter an equal amount of total 
protein was taken for immunoprecipitation followed by 
quantification of protein levels and kinase activities of 
the two tyrosine protein kinases. Western blotting data 
revealed that p~62~~y”” and ~~59~~ proteins were en- 
riched 2.4- and 1.4-fold, respectively, in the growth cone 
relative to the level in the cell body fraction (Fig. 1 and 
Table I). In the growth cones, the specific activities of 
p~62’-~~ and ~~59’~ were 1.8- and 2.3-fold higher than 
in the cell bodies (Table I). Thus, like pp60”” (Table I 
and [22]) the two examined src-related tyrosine kinase 
activities were enriched in SH-SYSY growth cones. 
3.2. Unlike ppdo”‘“, pp59fy” and pp62cWyes did not form 
complexes with a 38 kDa protein in the growth cones 
pp60” forms a complex with a 38 kDa protein (~~38) 
detected via its phosphorylation in a pp60”rc-immuno- 
complex kinase assay. pp38, which presumably associ- 
ated to ~~60”” via dis~fide-bridges, is strongly 
phosphorylated in the growth cone fraction but just 
detectable in the cell bodies of SH-SYSY cells (Fig. 2, 
lane 2, and [22]). To examine if the two other src-related 
kinases also were associated with pp38, kinase assays 
were performed using immunocomplexes obtained via 
anti-fyn and anti-yes immunoprecipitations of solubil- 
ized growth cone and cell body material. As seen in Fig. 
2, pp38 was not detected in ~~59~~ or pp62”*y”” im- 
munoprecipitates (lanes 3,4 and 5,6). Even after over- 
exposure of the autoradiogram of the in vitro tyrosine 
kinase analysis the pp38 was undetectable (not shown). 
However, the ppS9~~-immuno~omplex kinase reaction 
Table I 
Specific kinase activity of pp62’-yes. ~~59~~” and ~~60~ in a growth 
cone and a cell body preparation 
Cell body Growth cone* 
Pp62c-y” 
Protein 
Autophosphorylation activity 
Specific autophospho~lation 
activity 
PP59’- 
Protein 
Autophospho~lation activity 
Specific autophosphorylation 
activity 
ppcwc** 
Protein 
Autophosphorylation activity 
Specific autophosphorylation 
activity 
1.0 2.4 + 1.1 
1.0 4.3 ?r 1.9 
1.0 1.8 + 0.1 
1.0 1.4ro.1 
1.0 3.1 + 0.9 
1.0 2.3 & 0.7 
1.0 1.5 10.0 
1.0 3.2 + 0.1 
1.0 2.1 + 0.1 
*Mean value (arbitrary units) of two separate xperiments 
**Data taken from [22]. 
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Fig. I. Analysis of the specific pp62m and pp5p kinase activities in a cell body and a gtowth ame fraction from TPA-treated SH-SYSY cells. 
Growth cones and cell bodies prepared from diffbrentiating SH-SYSY eelIs were solubilized in RIPA buffer and normaiized for total Protein content. 
PP62 c-Yap and pp59‘y” were immunoprecipitated with anti-yes3 and antisfynl antibodies, respectively, and each immunoprecipitate was divided into 
two parts; 0.1 mg of total protein was used for kinase assay, and 0.5 mg for immunoblotting. [‘251]Protein A was used for the detection of the 
immunoreactive proteins in the immunoblot analysis. (A) Kinase assay of pp62 *yzr, (B) immunoblot of p~6T-~, (C) kinase assay of ppWfp, and 
(D) immunoblot of ppWm. (A-D) Lane I, cell body; lane 2, growth cone fraction. The radioactivity was quantified using a pbospho-imager 
analyzer and the values are pre~nted in Table I. 
identified a major additional protein with an approxi- 
mate moleclIfar weight of 90 kDa. This in vitro 
p~ospho~~at~ protein was particularily prominent in 
the growth cone fraction, but was also readily detected 
in the cell body preparation (Fig. 2, lanes 3 and 4). 
Eiectrophoretie analysis of the pp5gfy” immunoprecipi- 
tate under non-reducing conditions gave no indication 
that the 90 kDa protein was linked to pp5gfy” via disul- 
fide-bridges (data not shown). In contrast, no major 
phosphorylated proteins appeared to associate to 
~p62”~““, asjudged by the immunacomplex protein ki- 
nase analysis (Fig. 2, lanes 5 and 6). Some minor bands 
were detected, but phospho~lated prateins of similar 
molecular weights were also detected in the pp60” and 
pp5gfu” i~~~o~p~exes‘ Whether these phosphory- 
lated proteins resect true association ta members of the 
src-family or not is an open question. 
4. DISCUSSION 
The enrichment of pp60” [22,32] and the compIex 
formation with a 38 kDa protein in neuronal growth 
cones [22], suggest specific roles for these proteins in the 
growth cone. However, mice homozygous for a null 
mutation in the C-WC gene show no overt abnormaiities 
in the nervous system [Zs]. It is reasonable to assume, 
though, that the function of the c-SE isoforms in the 
nervous system in these animals are compensated by 
protein activities that are inte~ha~geable with the 
pp60s” kinase activity. Candidate proteins are pp5gfm 
and pp62c-yey”” since they are biochemically closely related 
to pp60”“, and have to a certain extent similar tissue 
distributions as ~~60”” [ 10,13,33-361. Thefyn and c-yes 
genes, respectively, have recently been knocked-out re- 
sulting in no (c-yes) or limited effects cfyn) on the nerv- 
ous system. In the f_~ knock-outs, long-term potentia- 
tion and the deve~o~ent of ~p~pa~ neurons were 
affected 137,381. However, ablation of two or more 
genes of the src-family might turn out to have profound 
effects on the development and function of the nervous 
system, 
In this report we show that pp5gfW and pp62”-y” were 
WC f yn Yes 
1234 56 
PP90 - 
Y@f+ 
srcJ= 
fyn’ 
w36-- 
Fig. 2. PPcio”“, but not pp5YfP and ~p62”~, forms a complex with 
pp38 in the growth cone fraction. The cell body and the growth cone 
fractions were solubiIiz.ed, divided into three parts, and immunopre- 
cipitated using the following antibodies; MAb 327 against pp60”’ 
(lanes 1,2), ant&&n1 against pp59fy” (lanes 3,4), and anti-yes3 against 
~p42*~ (lanes 5,6). The ~un~omplexes were analysed for kinase 
activity and the phosphoryfated proteins were analysed by SDS- 
PAGE and auto~dio~phy. Lanes I, 3 and 5, represent cell body; 
lanes 2,4 and 6, represent he growth cone material. 
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slightly enriched and activated in growth cones from 
differentiating SH-SYSY cells. Qualitatively, the same 
distribution and activation patterns were observed for 
these two kinases as for pp60”, as determined previ- 
ously [22]. Thus, our data could support the idea that 
redundancy mechanisms explain why animals lacking 
the src gene still have the capacity to form neuronal 
growth cones. However, neither pp5gfy” nor pp62”-y”’ 
was associated with the 38 kDa protein in growth cones 
or in cell bodies, which distin~ishes pp60” from the 
two other kinases. The result was somewhat unexpected 
since ~~62”~~ complexes with a 38 kDa protein in adult 
rat cerebellum 1241. A number of reasonable explana- 
tions can be suggested. One is that the cerebellar pp38 
is not identical to pp38 in SH-SYSY cells, and that the 
former pp38 is not expressed in these cells. Another 
explanation would be that the pp62”*Yes-pp38 complex 
is formed at later developmental stages than the corre- 
sponding complex with pp60”“, and that SH-SYSY cells 
represent a ~fferentiation stage at which pp38 does not 
complex with ~~62”~. A third possibility is that 
pp6TY”” and pp60” have different lo~lizations in the 
SH-SYSY growth cones, and that pp60” co-localizes 
with pp38. 
Immunoprecipitates of pp59@ contained a 90 kDa 
protein that was heavily phosphorylated in the SH- 
SY.5-Y growth cones as detected by the in vitro kinase 
assay. In contrast, no major additional phosphorylated 
proteins were found in the pp62”Yes immunocomplex. 
Thus, the src-related tyrosine kinases in SH-SYSY 
growth cones differed in their associations to other pro- 
teins, and presumably this reflects differences in their 
specific growth cone fictions. The isolation and struc- 
tural charact~ation of pp38 or corresponding cDNA 
might therefore disclose the role(s) of pp60” in growth 
cones, and shed some light over its function in neurons. 
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